Lower hospitalization rates - even with heart failure - Medizinonline

The results of a pre-specified exploratory analysis of the DANFLU-2 study indicate that the administration of a high-dose inactivated influenza vaccine could provide additional protection in patients with cardiovascular disease. The DANFLU-2 study was conducted in Denmark in the period 2022-2025 over three consecutive influenza seasons.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Mirjam Peter, M.Sc.

Publikation

HAUSARZT PRAXIS
InFo PNEUMOLOGIE & ALLERGOLOGIE

Related Topics

Previous Article

From statins to metformin

Preventive pharmacology and longevity

Oncology

Study updates from the ESMO Congress

You May Also Like

7 min

Obesity: A Multimodal and Interdisciplinary Approach

New Swiss Clinical Practice Guideline Provides Guidance

7 min

cSCC: Personalizing Treatment Strategies and Follow-up Care Plans

Comprehensive risk stratification is no simple matter: what’s new?

12 min

Baxdrostat – a new class of drugs for treating difficult-to-control hypertension

First Aldosterone Synthase Inhibitor Is Here

3 min

Geriatric Small-Cell Lung Cancer

Therapeutic Challenges

- RX
- Education
- Geriatrics
- Oncology
- Pneumology
- Studies

8 min

Chronic Pruritus in Renal, Hepatic, and Biliary Tract Diseases

Pooled Expertise for Targeted Evaluation and Treatment

6 min

Advanced Thyroid Cancer

Molecular Mechanisms and New Therapeutic Approaches

4 min

Epidermolysis bullosa

Promoting Wound Healing with Gene Therapies and Birch Bark Extract

18 min

From Risk Identification to Anti-Inflammatory Intervention

Inflammation as a Treatment Goal in Its Own Right

Input your search keywords and press Enter.